AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7640102
Drug: iopamidol 370
RxNorm normalized name: iopamidol 370 mg iodine/mL (76 %) INTRAVEN KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iopamidol 370 mg I/ml
Trial: 2769441
Drug: No therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No therapy for five days followed by acupressure wristbands for five days
Trial: 24140326
Drug: Capsicum (2g/cow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsicum (2g/cow daily)
Trial: 24140326
Drug: Garlic (2g/cow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Garlic (2g/cow daily)
Trial: 24140326
Drug: Phytonutrients (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phytonutrients (all treatments)
Trial: 20875186
Drug: Carbohydrate-milk protein
RxNorm normalized name: milk protein concentrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-milk protein solution (40 g/l carbohydrate, 25 g/l milk protein)
Trial: 20875186
Drug: Carbohydrate solution
RxNorm normalized name: phosphorated carbohydrate solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate solution (65 g/l carbohydrate)
Trial: 19017760
Drug: 54 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 54 mg/d genistein for 24 weeks
Trial: 19017760
Drug: 54 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 54 mg/d genistein for 24 weeks (normoinsulinemic subgroup)
Trial: 19017760
Drug: 54 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 54 mg/d genistein for 24 weeks (hyperinsulinemic subgroup)
Trial: 15104196
Drug: Nasal triamcinolone
RxNorm normalized name: triamcinolone Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal triamcinolone acetonide (220 microg once daily) for 6 weeks
Trial: 15104196
Drug: No intranasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intranasal corticosteroid treatment
Trial: 9848301
Drug: Triptorelin (3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptorelin (3.75 mg IM)
Trial: 8006332
Drug: Tetracycline instillation
RxNorm normalized name: Tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracycline instillation (100 mg/ml, range: 1-4 ml)
Trial: 7249528
Drug: Cimetidine (H2-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (H2-receptor antagonist)
Trial: 901705
Drug: Cimetidine +
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine + Chlorpheniramine (H1-receptor antagonist)
Trial: 31410963
Drug: Experimental arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Experimental arm (anticancer therapies)
Trial: 31410963
Drug: Control arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control arm (anticancer therapies)
Trial: 16953985
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg E2V/2.5 mg MPA daily (1 + 2.5 group)
Trial: 16953985
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg E2V/5 mg MPA daily (1 + 5 group)
Trial: 16953985
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg E2V/2.5 mg MPA daily (2 + 2.5 group)
Trial: 16953985
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg E2V/5 mg MPA daily (2 + 5 group)
Trial: 16953985
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of ccHRT
Trial: 16987360
Drug: Intravenous paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous paracetamol (1 g every 6 hours)
Trial: 16987360
Drug: Rectal paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal paracetamol (1 g every 6 hours)
Trial: 10592405
Drug: Isotrexin (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotrexin (combination of isotretinoin 0.05% and erythromycin 2%)
Trial: 7491888
Drug: OB diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OB diet (oat bran bread, 12.5 g beta-glucan/d)
Trial: 7491888
Drug: OBE diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OBE diet (oat bran with beta-glucanase, 3.8 g beta-glucan/d)
Trial: 7491888
Drug: B diet
RxNorm normalized name: chromocarb diethylamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: B diet (barley, 13.0 g beta-glucan/d)
Trial: 7491888
Drug: W diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: W diet (wheat flour, 1.2 g beta-glucan/d)
Trial: 2344168
Drug: 1% mercuric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% mercuric oxide ophthalmic ointment, treated twice daily for 7 days
Trial: 7002691
Drug: Propranolol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (2 mg bolus followed by 0.1 mg/Kg/die for the next 48 hours in continuous i.v. infusion)
Trial: 31690980
Drug: Eluvia Drug-Eluting
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eluvia Drug-Eluting Vascular Stent System
Trial: 31690980
Drug: Zilver PTX
RxNorm normalized name: PTX-100
DrugBank: PTX-100 (DB18125)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zilver PTX Drug-Eluting Peripheral Stent
Trial: 31395113
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of oral habits
Trial: 28946582
Drug: Shaker exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shaker exercise and conventional dysphagia therapy
Trial: 30426133
Drug: Conventional dysphagia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dysphagia therapy
Trial: 25622199
Drug: SS plus
RxNorm normalized name: BSS Plus
DrugBank: Sodium phosphate, dibasic, unspecified form (DB14504)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SS plus sertraline
Trial: 23710672
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing, and one or more of periodontal surgery, systemically administered amoxicillin + metronidazole or local tetracycline at pockets ≥5 mm
Trial: 11395033
Drug: Apo A-IV
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Apo A-IV infusion with deuterated leucine over a 15 h time period with hourly feeding; TRL separated by ultracentrifugation; apo A-IV isolated by immunoprecipitation and/or SDS-PAGE.
Trial: 11395033
Drug: Apo A-IV
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Apo A-IV infusion with deuterated leucine; TRL and plasma apo A-IV residence times (RT) and transport rates (TR) measured.
Trial: 9426382
Drug: CHO+ (50g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO+ (50g carbohydrates, 200 micrograms chromium-picolinate, 20g soluble fibre, 100 mg caffeine)
Trial: 3574137
Drug: Aspartame in
RxNorm normalized name: Aspartame
DrugBank: Aspartame (DB00168)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame in solution (3 g)
Trial: 3574137
Drug: Aspartame in
RxNorm normalized name: Aspartame
DrugBank: Aspartame (DB00168)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame in capsules (3 g)
Trial: 30798084
Drug: Chemotherapy continuation
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy continuation (CT-CONT)
Trial: 30798084
Drug: Chemotherapy discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy discontinuation (CT-DISC)
Trial: 21256179
Drug: Acetyl-l-Carnitine (3g/day)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-l-Carnitine (3g/day)
Trial: 21256179
Drug: Acetyl-l-Carnitine (1g/day)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-l-Carnitine (1g/day)
Trial: 19551353
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine ophthalmic emulsion 0.05%
Trial: 21397805
Drug: Artificial tear
RxNorm normalized name: Artificial Tears
DrugBank: Polyethylene glycol 400 (DB11077)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial tear solution
Trial: 15295720
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg daily for one month
Trial: 9665097
Drug: Strong black
RxNorm normalized name: acid black 52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strong black tea (1600 mL/d)
Trial: 9665097
Drug: Fried onions
RxNorm normalized name: ONION
DrugBank: Onion (DB10548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fried onions (129 g/d)
Trial: 9665097
Drug: Fried onions
RxNorm normalized name: ONION
DrugBank: Onion (DB10548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fried onions (129 g/d) repeated treatment
Trial: 31621189
Drug: VYC-12 injectable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VYC-12 injectable gel
Trial: 23820423
Drug: Unilateral laparoscopic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral laparoscopic ovarian drilling (ULOD) with thermal doses adjusted to the volume of the right ovary (60 J/cm³)
Trial: 23820423
Drug: Bilateral laparoscopic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral laparoscopic ovarian drilling (BLOD) with fixed doses of 600 J per ovary
Trial: 19960974
Drug: Bailing Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bailing Capsule (BC) and benazepril
Trial: 16520478
Drug: Herbal medicine
RxNorm normalized name: Herbal medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal medicine interventions
Trial: 16520478
Drug: Item 4
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Item 4 concerning herbal medicine intervention
Trial: 15574604
Drug: 4% amethocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% amethocaine gel (1 g applied for 30 minutes before vaccination)
Trial: 15574604
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 g applied for 30 minutes before vaccination)
Trial: 10809936
Drug: High-dose rivastigmine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose rivastigmine (6-12 mg/day)
Trial: 10809936
Drug: Low-dose rivastigmine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rivastigmine (1-4 mg/day)
Trial: 1472143
Drug: terfenadine 120
RxNorm normalized name: terfenadine 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terfenadine 120 mg once daily
Trial: 6708399
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg fenoterol powder
Trial: 31562911
Drug: Probiotic VSL#3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic VSL#3 taken just before operation and twice daily up to 15 total doses
Trial: 23229869
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg low-dose intrathecal bupivacaine
Trial: 23229869
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg standard-dose intrathecal bupivacaine
Trial: 10672630
Drug: Caffeine (equal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (equal to baseline daily caffeine consumption)
Trial: 9327317
Drug: Metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 100 mg orally before surgery and once daily postoperatively
Trial: 4003987
Drug: Intramuscular recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular recombinant interferon alpha‐2 at dosages of 10 to 50 MU/d
Trial: 4003987
Drug: Intravenous recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous recombinant interferon alpha‐2 at dosages of 10 to 50 MU/d
Trial: 3067408
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate standard tablets (nitrosorbide-NS) at a dose of 10 mg per os
Trial: 3067408
Drug: Sublingual NS
RxNorm normalized name: NS-2359
DrugBank: NS-2359 (DB05805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual NS administration
Trial: 3067408
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate prolonged action isomac-retard containing 40 mg
Trial: 3067408
Drug: Increased NS
RxNorm normalized name: NS-2359
DrugBank: NS-2359 (DB05805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased NS dose per os
Trial: 29179016
Drug: Group family-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group family-based cognitive behavioral therapy (GF-CBT)
Trial: 25743819
Drug: EAAL treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EAAL treatment group
Trial: 15673841
Drug: Modified constraint-induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified constraint-induced therapy (mCIT)
Trial: 18174447
Drug: No-treatment control
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No-treatment control regimen
Trial: 1320916
Drug: Alizapride (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alizapride (12 mg/kg) plus Dexamethasone (8 mg)
Trial: 1320916
Drug: Metoclopramide (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (7 mg/kg) plus Dexamethasone (12 mg)
Trial: 6375273
Drug: Subcutaneous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Subcutaneous low-dose heparin 5000 IU every 12 hours
Trial: 29686818
Drug: Standard neuromotor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard neuromotor rehabilitation treatment
Trial: 26725544
Drug: Opicapone 5
RxNorm normalized name: opicapone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opicapone 5 mg
Trial: 3185464
Drug: Zolpidem (hypnotic)
DrugBank: Zolpidem (DB00425)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zolpidem (hypnotic)
Trial: 30715535
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg Se from SY
Trial: 30715535
Drug: 1.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg/kg Se from SY
Trial: 30715535
Drug: 3.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 mg/kg Se from SY
Trial: 30715535
Drug: 0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg/kg Se from SY (basal diet)
Trial: 27838474
Drug: Personalized AHFS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized AHFS treatments (specific treatments not detailed)
Trial: 27838474
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment with intravenous diuretics (control group)
Trial: 15176647
Drug: A6 15
RxNorm normalized name: Chlorin a6
DrugBank: Phytochlorin (DB19265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A6 15 mg
Trial: 15176647
Drug: A6 35
RxNorm normalized name: Chlorin a6
DrugBank: Phytochlorin (DB19265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A6 35 mg
Trial: 15176647
Drug: A6 75
RxNorm normalized name: Chlorin a6
DrugBank: Phytochlorin (DB19265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A6 75 mg
Trial: 15176647
Drug: A6 150
RxNorm normalized name: Chlorin a6
DrugBank: Phytochlorin (DB19265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A6 150 mg
Trial: 15176647
Drug: A6 300
RxNorm normalized name: Chlorin a6
DrugBank: Phytochlorin (DB19265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A6 300 mg
Trial: 15176647
Drug: A6 35
RxNorm normalized name: Chlorin a6
DrugBank: Phytochlorin (DB19265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A6 35 mg repeated doses
Trial: 15176647
Drug: A6 75
RxNorm normalized name: Chlorin a6
DrugBank: Phytochlorin (DB19265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A6 75 mg repeated doses
Trial: 15176647
Drug: A6 150
RxNorm normalized name: Chlorin a6
DrugBank: Phytochlorin (DB19265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A6 150 mg repeated doses
Trial: 11533546
Drug: Intravenous liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous liposomal amphotericine B + oral itraconazole
Trial: 12122510
Drug: Intravenous fluconazole
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous fluconazole + oral itraconazole
Trial: 9793313
Drug: Prednisone 40
RxNorm normalized name: prednisone 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 40 mg/day
Trial: 31595803
Drug: Medication usage
RxNorm normalized name: SAGE
DrugBank: Sage (DB10982)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication usage recorded as a treatment for nausea AEs (76% of cases)
Trial: 29578944
Drug: PF‐05089771 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF‐05089771 150 mg twice daily
Trial: 30136102
Drug: Pregabalin 150
RxNorm normalized name: pregabalin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 150 mg twice daily
Trial: 28424870
Drug: Concurrent high-intensity
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent high-intensity interval training (CT)
Trial: 15657474
Drug: CAF (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAF (5 mg/kg)
Trial: 15657474
Drug: CAF (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAF (3 mg/kg)
Trial: 15657474
Drug: CAF (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAF (7 mg/kg)
Trial: 2082718
Drug: Dydrogesterone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dydrogesterone (20 mg/day during the last 12 days of the menstrual cycle)
Trial: 299221
Drug: Chemo-Immunotherapy consisting
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemo-Immunotherapy consisting of 5-Fluorouracil and CCNU and Corynebacterium parvum administered intermittently for one year.
Trial: 31782768
Drug: 9 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 × 105 PfSPZ Vaccine
Trial: 31782768
Drug: 1.8 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 × 106 PfSPZ Vaccine
Trial: 26179504
Drug: Metformin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (500 mg three times per day for 3 days before surgery)
Trial: 17906207
Drug: Paclitaxel 135
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 135 mg/m2 during 24 hours (arm 1)
Trial: 17906207
Drug: Paclitaxel 120
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 120 mg/m2 during 96 hours (arm 2)
Trial: 8703860
Drug: 6 mm
RxNorm normalized name: I-Port, 6 mm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mm treatment
Trial: 8703860
Drug: 5 mm
RxNorm normalized name: SUR-FIT 45 mm Wafer, Small
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mm treatment
Trial: 8703860
Drug: Multizone treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multizone treatment
Trial: 31686109
Drug: Adjuvanted recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvanted recombinant glycoprotein E herpes zoster vaccine
Trial: 26657263
Drug: Intra-articular corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular corticosteroid injection with betamethasone
Trial: 21508180
Drug: Propafenone 150
RxNorm normalized name: propafenone 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 150 mg 3 times daily with quinidine 100 mg twice daily
Trial: 21508180
Drug: Propafenone 150
RxNorm normalized name: propafenone 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 150 mg 3 times daily with placebo
Trial: 12511809
Drug: Active medication
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active medication (buspirone or fluoxetine)
Trial: 7622822
Drug: Selective serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective serotonin reuptake inhibitors (SSRIs) in placebo controlled trials
Trial: 7622822
Drug: Tricyclic antidepressants
RxNorm normalized name: TRICYCLIC ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tricyclic antidepressants (TCAs) in placebo controlled trials
Trial: 379932
Drug: Levamisole as
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole as adjunctive treatment between cycles of chemotherapy
Trial: 379932
Drug: Conventional high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional high dose chemotherapy
Trial: 31887090
Drug: AB‐ace (alfaxalone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AB‐ace (alfaxalone [2 mg/kg] and butorphanol [0.4 mg/kg] combined with acepromazine [0.02 mg/kg])
Trial: 31887090
Drug: AB‐mid (alfaxalone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AB‐mid (alfaxalone [2 mg/kg] and butorphanol [0.4 mg/kg] combined with midazolam [0.2 mg/kg])